Get startedLog in
    Picture of Global Cord Blood logo

    CORBF — Global Cord Blood Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Global Cord Blood, fiscal year end - March 31st, CNY millions except per share, conversion factor applied.

    2018
    March 31st
    2019
    March 31st
    2020
    March 31st
    2021
    March 31st
    2022
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:20-F20-F20-F20-F20-F
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line241295478516509
    Depreciation
    Amortisation
    Deferred Taxes
    Non-Cash Items11795.84014.256.7
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital42036364.158.3-3.77
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Taxes Payable
    Change in Other Liabilities
    Cash from Operating Activities819792624631614
    Capital Expenditures-67.1-30.7-24.2-20.9-19.8
    Purchase of Fixed Assets
    Other Investing Cash Flow Items0.5890.479-1220.7850.154
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Cash from Investing Activities-66.5-30.2-146-20.1-19.6
    Financing Cash Flow Items-2.02-3.02-4.04-6.07-7.73
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-2.02-21.2-4.04-6.07-7.73
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash740747476602585